|
| 38086269 | WB518, a novel STAT3 inhibitor, effectively alleviates IMQ and TPA-induced animal psoriasis by inhibiting STAT3 phosphorylation and Keratin 17. | Int Immunopharmacol | 2024 |
| 36374556 | Selectively Targeting STAT3 Using a Small Molecule Inhibitor is a Potential Therapeutic Strategy for Pancreatic Cancer. | Clin Cancer Res | 2023 |
| 37634473 | A small molecule BCL6 inhibitor as chemosensitizers in acute myeloid leukemia. | Biomed Pharmacother | 2023 |
| 38054798 | Discovery of a Highly Potent and Selective MYOF Inhibitor with Improved Water Solubility for the Treatment of Gastric Cancer. | J Med Chem | 2023 |
| 37143950 | Combined treatment of disulfiram with PARP inhibitors suppresses ovarian cancer. | Front Oncol | 2023 |
| 37334274 | Preclinical characterization of WB737, a potent and selective STAT3 inhibitor, in natural killer/T-cell lymphoma. | MedComm (2020) | 2023 |
| 34740924 | Single-Cell Analysis Reveals EP4 as a Target for Restoring T-Cell Infiltration and Sensitizing Prostate Cancer to Immunotherapy. | Clin Cancer Res | 2022 |
| 35476936 | Discovery of 2-Amino-3-cyanothiophene Derivatives as Potent STAT3 Inhibitors for the Treatment of Osteosarcoma Growth and Metastasis. | J Med Chem | 2022 |
| 36103247 | Discovery of a Novel Potent STAT3 Inhibitor HP590 with Dual p-Tyr<sup>705</sup>/Ser<sup>727</sup> Inhibitory Activity for Gastric Cancer Treatment. | J Med Chem | 2022 |
| 36165130 | Discovery of 1,5-diaryl-1,2,4-triazole derivatives as myoferlin inhibitors and their antitumor effects in pancreatic cancer. | Future Med Chem | 2022 |
| 35121048 | A novel small-molecule activator of unfolded protein response suppresses castration-resistant prostate cancer growth. | Cancer Lett | 2022 |
| 34990752 | An orally available small molecule BCL6 inhibitor effectively suppresses diffuse large B cell lymphoma cells growth in vitro and in vivo. | Cancer Lett | 2022 |
| 33420372 | Targeting STAT3 by a small molecule suppresses pancreatic cancer progression. | Oncogene | 2021 |
| 33634965 | A potent and selective small molecule inhibitor of myoferlin attenuates colorectal cancer progression. | Clin Transl Med | 2021 |
| 33687738 | The natural product trienomycin A is a STAT3 pathway inhibitor that exhibits potent in vitro and in vivo efficacy against pancreatic cancer. | Br J Pharmacol | 2021 |
| 34150618 | Regression of Castration-Resistant Prostate Cancer by a Novel Compound HG122. | Front Oncol | 2021 |
| 33283987 | Reprogramming immunosuppressive myeloid cells facilitates immunotherapy for colorectal cancer. | EMBO Mol Med | 2021 |
| 33420488 | Single-cell analysis reveals transcriptomic remodellings in distinct cell types that contribute to human prostate cancer progression. | Nat Cell Biol | 2021 |
| 32168548 | Determining the Drug-Like Properties of Ailanthone, a Novel Chinese Medicine Monomer with Anti-CRPC Activity. | Planta Med | 2020 |
| 35025480 | A Mussel-Inspired Extracellular Matrix-Mimicking Composite Scaffold for Diabetic Wound Healing. | ACS Appl Bio Mater | 2020 |
| 31758659 | Ethyl-N-dodecanoyl-l-arginate hydrochloride combats pathogens with low-resistance generation by membrane attack and modifies gut microbiota structure. | Microb Biotechnol | 2020 |
| 31812467 | Synthesis and anticancer activity of novel 9,13-disubstituted berberine derivatives. | Bioorg Med Chem Lett | 2020 |
| 32078862 | Design, synthesis and evaluation of phenylthiazole and phenylthiophene pyrimidindiamine derivatives targeting the bacterial membrane. | Eur J Med Chem | 2020 |
| 31895575 | Synthesis and Biological Evaluation of B-Cell Lymphoma 6 Inhibitors of <i>N</i>-Phenyl-4-pyrimidinamine Derivatives Bearing Potent Activities against Tumor Growth. | J Med Chem | 2020 |
| 31952596 | Characterization and optimization of production of bacterial cellulose from strain CGMCC 17276 based on whole-genome analysis. | Carbohydr Polym | 2020 |
| 32002708 | Regression of castration-resistant prostate cancer by a novel compound QW07 targeting androgen receptor N-terminal domain. | Cell Biol Toxicol | 2020 |
| 31972471 | Corrigendum to 'Inhibition of HDACs-EphA2 signaling axis with WW437 demonstrates promising preclinical antitumor activity in breast cancer' [EBioMedicine 31 (2018) 276-286]. | EBioMedicine | 2020 |
| 32216291 | Copper-Based Metal-Organic Framework as a Controllable Nitric Oxide-Releasing Vehicle for Enhanced Diabetic Wound Healing. | ACS Appl Mater Interfaces | 2020 |
| 32382484 | Targeting Pyruvate Carboxylase by a Small Molecule Suppresses Breast Cancer Progression. | Adv Sci (Weinh) | 2020 |
| 30638240 | Diastereoselective synthesis of 3,3-disubstituted 3-nitro-4-chromanone derivatives as potential antitumor agents. | Org Biomol Chem | 2019 |
| 35528914 | Synthesis and biological evaluation of 3-nitro-4-chromanone derivatives as potential antiproliferative agents for castration-resistant prostate cancer. | RSC Adv | 2019 |
| 35520707 | Discovery of methylpyrimidine ring-fused diterpenoid analogs as a novel testosterone synthesis promoter. | RSC Adv | 2019 |
| 35016283 | Space-Oriented Nanofibrous Scaffold with Silicon-Doped Amorphous Calcium Phosphate Nanocoating for Diabetic Wound Healing. | ACS Appl Bio Mater | 2019 |
| 31640758 | A novel BMI-1 inhibitor QW24 for the treatment of stem-like colorectal cancer. | J Exp Clin Cancer Res | 2019 |
| 31553023 | An aligned porous electrospun fibrous scaffold with embedded asiatic acid for accelerating diabetic wound healing. | J Mater Chem B | 2019 |
| 30835100 | Correction to Electrospun Micropatterned Nanocomposites Incorporated with Cu<sub>2</sub>S Nanoflowers for Skin Tumor Therapy and Wound Healing. | ACS Nano | 2019 |
| 30709873 | Correction: Celastrol Suppresses Angiogenesis-Mediated Tumor Growth through Inhibition of AKT/Mammalian Target of Rapamycin Pathway. | Cancer Res | 2019 |
| 31091478 | Synthesis and biological evaluation of methylpyrimidine-fused tricyclic diterpene analogs as novel oral anti-late-onset hypogonadism agents. | Eur J Med Chem | 2019 |
| 31026162 | Modification and Biological Evaluation of a Series of 1,5-Diaryl-1,2,4-triazole Compounds as Novel Agents against Pancreatic Cancer Metastasis through Targeting Myoferlin. | J Med Chem | 2019 |
| 30572284 | Chinese sesame stick-inspired nano-fibrous scaffolds for tumor therapy and skin tissue reconstruction. | Biomaterials | 2019 |
| 29454159 | An aligned porous electrospun fibrous membrane with controlled drug delivery - An efficient strategy to accelerate diabetic wound healing with improved angiogenesis. | Acta Biomater | 2018 |
| 30213946 | A small molecule targeting myoferlin exerts promising anti-tumor effects on breast cancer. | Nat Commun | 2018 |
| 30429953 | Synthesis of Cyanoenone-Modified Diterpenoid Analogs as Novel Bmi-1-Mediated Antitumor Agents. | ACS Med Chem Lett | 2018 |
| 30452224 | Correction to Copper Silicate Hollow Microspheres-Incorporated Scaffolds for Chemo-Photothermal Therapy of Melanoma and Tissue Healing. | ACS Nano | 2018 |
| 29518321 | Copper Silicate Hollow Microspheres-Incorporated Scaffolds for Chemo-Photothermal Therapy of Melanoma and Tissue Healing. | ACS Nano | 2018 |
| 29759486 | Inhibition of HDACs-EphA2 Signaling Axis with WW437 Demonstrates Promising Preclinical Antitumor Activity in Breast Cancer. | EBioMedicine | 2018 |
| 28713016 | A conducive bioceramic/polymer composite biomaterial for diabetic wound healing. | Acta Biomater | 2017 |
| 32263946 | A patterned nanocomposite membrane for high-efficiency healing of diabetic wound. | J Mater Chem B | 2017 |
| 28257652 | Ailanthone: a new potential drug for castration-resistant prostate cancer. | Chin J Cancer | 2017 |
| 28194552 | A novel synthetic small molecule YF-452 inhibits tumor growth through antiangiogenesis by suppressing VEGF receptor 2 signaling. | Sci China Life Sci | 2017 |